MedTrace Logo

Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery

NCT02166372 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2014-06-18

No results posted yet for this study

Summary

T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.

The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.

Conditions

Interventions

OTHER

Observation of natural course of Diabetes Mellitus Type 2

Sponsors & Collaborators

  • Min-Sheng General Hospital

    lead OTHER

Principal Investigators

  • Wei-Jei Lee, MD PhD · Min-Sheng General Hospital; National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2024-12-31
Completion
2034-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02166372 on ClinicalTrials.gov